Look beyond the published assurance to the arrangement that sustains it

I would ask a service board to look carefully at the distance between a public statement and the arrangements that make it dependable. A location, an opening time or an explanation of how to ask a question may appear too small for the board's attention. The individual wording usually is an executive matter. The underlying pattern can nevertheless be material: whether management knows who owns its public facts, recognises unresolved dependencies and understands the practical experience its promises assume.

My experience of that pattern comes from healthcare marketing, not clinical practice. At Orlaven Health I lead the marketing function and have presented relevant matters to the board as an executive since July 2020. I do not hold a director seat or a clinical qualification. A first appointment would require me to contribute across a wider range of responsibilities while respecting the professional authority already present. The useful contribution would be a way of questioning an assurance, rather than an attempt to become the board's editor or service manager.

The location audit illustrates the distinction. We reviewed 196 selected entries across fourteen locations and identified eighty-six requiring work. At the end of the initial programme, nine external corrections remained unconfirmed. It would have been easy to report the requests sent as the corrections achieved. I kept the unresolved category visible. At board level, the relevant question is how management distinguishes work within its control from the external result it is relying upon. The answer should help directors understand the remaining issue without drawing them into each directory amendment.

The contact-route review raises a different question about the assumptions in a proposed operating model. Nine of twenty-four selected participants sought telephone help during fictional administrative tasks. The observation supported retaining a visible choice; it did not establish what every patient would prefer. A board examining a digital access proposal should be able to ask who may need another route and what resources support it. Marketing can explain an option accurately only if operations can define what is actually available. Neither the page nor the board discussion should imply a clinical decision that belongs elsewhere.

I would also examine how the organisation treats information offered by people using its services. In the listening programme, participation concerned administrative difficulties. It did not create permission for a public story. That distinction matters to an enterprise's account of its relationships, even when a marketing opportunity appears attractive. I would want management to explain the purpose, the proposed use and the review required when that use changes. Individual consent arrangements and professional requirements need appropriate expertise; a director's enthusiasm for an example is not a substitute.

A healthcare board also needs to know when a marketing perspective is insufficient. Financial sustainability, clinical quality, workforce responsibilities and many other matters require competence beyond my function. I would prepare for those discussions and learn from the relevant directors and executives, rather than translate every issue into a brand question. I am not proposing immediate committee-chair responsibility. A suitable customer, service or strategy committee could offer a defined place for my experience, with a remit that preserves clinical and executive accountabilities.

Before an appointment, I would examine relationships with my employer, agencies, suppliers and professional contacts, obtain required consent and assess the proposed calendar. Twenty-two annual days are provisional capacity, not a statement that all boards make comparable demands. Confidential information from one role must not become an unspoken contribution to another. A company seeking access to Orlaven's network, or a marketing assignment disguised as a directorship, would not fit the role I am considering.

I would want a chair to assess whether my questions make the collective discussion more precise: what is promised, what supports it, what remains unknown and who is responsible for the next decision. I would also expect feedback when my contribution stays too close to my executive specialism. That combination of relevant experience and willingness to learn is the basis on which I would explore a first appointment. The profile explains the proposal; it does not determine eligibility or independence for an unidentified company.